ABSTRACT
About POC Lipid Testing
Point-of-care (POC) lipid testing is used to measure the lipid level of the blood at a convenient place near the patient. The test also measures high-density lipoprotein (HDL), low-density lipoprotein (LDL), cholesterol, and triglyceride level of the blood. POC tests help reduce the time between the diagnosis and treatment of a disease. They are antibody-based or microbial particle-based detection methods. A healthcare professional or a nurse obtains the testing samples from a patient, performs the analysis, and records the result. These tests include enzyme-linked immunosorbent assays (ELISA), agglutination tests, and lateral flow immunochromatography.
Technavio’s analysts forecast the global POC lipid testing market to grow at a CAGR of 6.28% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global POC lipid testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various types of products that are used for treatment.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global POC Lipid Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Alere
• F. Hoffmann-La Roche
• Abaxis
Other prominent vendors
• Accutech
• Menarini Group
• Bio-Rad
• Biochemical Systems International
• Eurotrol
• General Life Biotechnology
• Helena
• Nova Biomedical
• Randox
• Samsung
• Jant Pharmacal
• SD Biosensor
Market driver
• Increasing healthcare expenditure and reimbursements
• For a full, detailed list, view our report
Market challenge
• Rising cost of POC lipid testing
• For a full, detailed list, view our report
Market trend
• Increasing adoption of POC lipid testing in home-based healthcare settings
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Global POC lipid testing market by product
PART 07: Market segmentation by end-user
• Market overview
• Hospitals
• Clinical diagnostic laboratories
• Home healthcare settings
PART 08: Geographical segmentation
• POC lipid testing market in Americas
• POC lipid testing market in EMEA
• POC lipid testing market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments
PART 11: Market trends
PART 12: Vendor landscape
• Competitive landscape
PART 13: Key vendor analysis
• Alere
• F. Hoffmann-La Roche
• Abaxis
• Key companies to watch
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global POC lipid testing market: Key highlights 2016
Exhibit 02: Global POC lipid testing market 2016-2021 ($ millions)
Exhibit 03: Factors impacting market growth 2016-2021
Exhibit 04: Five forces analysis
Exhibit 05: Market overview of global POC lipid testing market for consumables 2016
Exhibit 06: Global POC lipid testing consumables market 2016-2021 ($ millions)
Exhibit 07: Factors impacting growth of global POC lipid testing consumables market 2016-2021
Exhibit 08: Market overview of global POC lipid testing instruments market
Exhibit 09: Global POC lipid testing instruments market 2017-2021 ($ millions)
Exhibit 10: Growth factors for global POC lipid testing instruments market 2016-2021
Exhibit 11: Global POC lipid testing market by end-users 2016
Exhibit 12: Global POC lipid testing market segmentation by geography 2016
Exhibit 13: POC lipid testing market in Americas: Overview
Exhibit 14: POC lipid testing market in Americas 2016-2021 ($ billions)
Exhibit 15: Americas: Market metrics in various countries
Exhibit 16: POC lipid testing market in EMEA: Overview
Exhibit 17: POC lipid testing market in EMEA 2016-2021 ($ billions)
Exhibit 18: Market metrics in various countries in EMEA
Exhibit 19: POC lipid testing market in APAC: Overview
Exhibit 20: POC lipid testing market in APAC 2016-2021 ($ millions)
Exhibit 21: Market metrics in various countries in APAC
Exhibit 22: Representation of healthcare expenditure in 2014 and 2015 for different countries
Exhibit 23: Duration of different POC lipid testing instruments to provide results
Exhibit 24: Impact of drivers
Exhibit 25: Cost centralized lipid testing in laboratories in US
Exhibit 26: Comparison of costs for lipid testing per patient by different treatments
Exhibit 27: Impact of challenges
Exhibit 28: Competitive structure analysis of global POC lipid testing market 2016
Exhibit 29: Market share of top vendors in global POC lipid testing market 2016
Exhibit 30: Global POC lipid testing market: Competitive landscape 2016
Exhibit 31: Strategies for large and small companies in global POC lipid testing market
Exhibit 32: Alere: Key highlights
Exhibit 33: Alere: Strength assessment
Exhibit 34: Alere: Strategy assessment
Exhibit 35: Alere: Opportunity assessment
Exhibit 36: F. Hoffmann-La Roche: Key highlights
Exhibit 37: F. Hoffmann-La Roche: Strength assessment
Exhibit 38: F. Hoffmann-La Roche: Strategy assessment
Exhibit 39: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 40: Abaxis: Key highlights
Exhibit 41: Abaxis: Strength assessment
Exhibit 42: Abaxis: Strategy assessment
Exhibit 43: Abaxis: Opportunity assessment
